Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00483418 · ClinicalTrials.gov registry record
Survey of Testosterone Levels in Male Cancer Patients
A clinical trial, sponsored by Beth Israel Medical Center.
- Completed
- Registry status
- 425
- Enrollment target
NCT00483418: Completed study, sponsored by Beth Israel Medical Center.
NCT00483418 is a clinical trial that has completed, run by Beth Israel Medical Center. The registered enrollment target is 425 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00483418 has completed, sponsored by Beth Israel Medical Center.
- COMPLETED
- Registry status
- 425 participants
- Enrollment target
Study Summary
The purpose of this study is to survey the total serum testosterone levels in male patients with hormone-independent malignancies. The prevalence of hypogonadism is not known, but is thought to be significant. Results will be adjusted for age and stratified for type of cancer, stage, study site,and presence of opiate use for pain management, which is known to reduce testosterone levels.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 425 participants |
| Start Date | 2007-06 |
| Est. Completion | 2009-12 |
What the finished NCT00483418 record still lists
NCT00483418 is an observational study that tracks outcomes without assigning an intervention. The registered 425 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00483418 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00483418 about?
NCT00483418 is a clinical study titled "Survey of Testosterone Levels in Male Cancer Patients". The purpose of this study is to survey the total serum testosterone levels in male patients with hormone-independent malignancies. The prevalence of hypogonadism is not known, but is thought to be significant. Results will be adjusted for age and stratified for type of cancer, stage, study site,and ...
What is the current status of trial NCT00483418?
This trial is currently completed. The enrollment target is 425 participants. The study started on 2007-06. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00483418?
This trial is sponsored by Beth Israel Medical Center, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04265430 · 425 participants · Phase 4
Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors
- NCT04278690 · 425 participants · NA
Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit
- NCT05321368 · 425 participants · NA
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
- NCT05340738 · 425 participants · NA
AI-Based Fidelity Feedback to Enhance CBT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia